Attached files

file filename
8-K - FORM 8-K - BioCorRx Inc.bicx_8k.htm
EXHIBIT 16.1
 
July 7, 2014
 
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
 
Ladies and Gentlemen:
 
We have read BioCorRx, Inc.’s statements included under Item 4.01 of its Form 8-K dated July 7, 2014, and are in agreement with the statements contained therein concerning our Firm in response to Item 304(a) of Regulation S-K.
 
Regards,